{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:37:56Z","timestamp":1793194676055,"version":"4.5.0"},"reference-count":222,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20220469"],"award-info":[{"award-number":["BK20220469"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["Z2022020"],"award-info":[{"award-number":["Z2022020"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204934"],"award-info":[{"award-number":["82204934"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["XPT82204934"],"award-info":[{"award-number":["XPT82204934"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phymed.2026.158759","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:55:36Z","timestamp":1787813736000},"page":"158759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From molecular to microenvironmental reprogramming: Multi-target strategies of flavonoids to overcome paclitaxel resistance in triple-negative breast cancer"],"prefix":"10.1016","volume":"161","author":[{"given":"Meiling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8966-1934","authenticated-orcid":false,"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"01","key":"10.1016\/j.phymed.2026.158759_bib0001","doi-asserted-by":"crossref","first-page":"164","DOI":"10.36347\/sajb.2025.v13i01.017","article-title":"Phytochemicals as cancer immunotherapeutics: bridging natural compounds and advanced treatment strategies","volume":"13","author":"Akhtar","year":"2025","journal-title":"Scholars Acad. J. Biosci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22010062","article-title":"A novel role of silibinin as a putative epigenetic modulator in human prostate carcinoma","volume":"22","author":"Anestopoulos","year":"2016","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.phymed.2026.158759_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32070387","article-title":"Predictive factors of response to neoadjuvant chemotherapy (NACT) and immune checkpoint inhibitors in early-stage triple-negative breast cancer patients (TNBC)","volume":"32","author":"Ardakani","year":"2025","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12935-023-03052-z","article-title":"Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review","volume":"23","author":"Asnaashari","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"24","key":"10.1016\/j.phymed.2026.158759_bib0006","doi-asserted-by":"crossref","first-page":"33523","DOI":"10.1021\/acsami.5c24911","article-title":"Integrin alphavbeta3-targeted SLNs for Co-delivery of paclitaxel and quercetin in triple-negative breast cancer","volume":"18","author":"Azadi","year":"2026","journal-title":"ACS. Appl. Mater. Interfaces."},{"issue":"4","key":"10.1016\/j.phymed.2026.158759_bib0007","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1007\/s00210-024-03523-8","article-title":"Synergistic ferroptosis in triple-negative breast cancer cells: paclitaxel in combination with Erastin induced oxidative stress and Ferroportin-1 modulation in MDA-MB-231 cells","volume":"398","author":"Bakar-Ates","year":"2024","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"issue":"7769","key":"10.1016\/j.phymed.2026.158759_bib0008","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158759_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2026.158759_bib0010","article-title":"Plant flavonoid effects on the non-apoptotic mechanisms of regulated cell death","author":"Bia\u0142ek","year":"2025","journal-title":"Phytochem. Rev."},{"issue":"19","key":"10.1016\/j.phymed.2026.158759_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911746","article-title":"A comprehensive analysis and anti-cancer activities of quercetin in ROS-mediated cancer and cancer stem cells","volume":"23","author":"Biswas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.phymed.2026.158759_bib0012","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41388-024-03025-0","article-title":"NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells","volume":"43","author":"Bottoni","year":"2024","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0013","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.phymed.2026.158759_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114634","article-title":"Control of biomedical nanoparticle distribution and drug release in vivo by complex particle design strategies","volume":"208","author":"Bresinsky","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0015","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen international consensus guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030232","article-title":"Metal organic frameworks as drug targeting delivery vehicles in the treatment of cancer","volume":"12","author":"Cai","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7910","key":"10.1016\/j.phymed.2026.158759_bib0017","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","article-title":"Design of protein-binding proteins from the target structure alone","volume":"605","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158759_bib0018","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2147\/IJN.S244849","article-title":"Paclitaxel-loaded macrophage membrane camouflaged albumin nanoparticles for targeted cancer therapy","volume":"15","author":"Cao","year":"2020","journal-title":"Int J Nanomed."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0019","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phymed.2026.158759_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919880429","article-title":"Novel therapeutic avenues in triple-negative breast cancer: PI3K\/AKT inhibition, androgen receptor blockade, and beyond","volume":"11","author":"Chan","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib224","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1021\/acs.nanolett.4c05782","article-title":"Biomimetic Nanoparticles Inhibit the HIF-1\u03b1\/iNOS\/NLRP3 Pathway to Alleviate Rheumatoid Arthritis","volume":"25","author":"Chen","year":"2025","journal-title":"Nano Letters"},{"issue":"38","key":"10.1016\/j.phymed.2026.158759_bib0021","doi-asserted-by":"crossref","first-page":"45201","DOI":"10.1021\/acsami.1c11032","article-title":"Metal\u2013organic framework-based nanoagents for effective tumor therapy by dual dynamics-amplified oxidative stress","volume":"13","author":"Chen","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phymed.2026.158759_bib0022","first-page":"1557","article-title":"Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study","volume":"11","author":"Chen","year":"2016","journal-title":"Int J Nanomed."},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0023","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/jcph.304","article-title":"Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: disposition kinetics and pharmacology distinct from solvent-based paclitaxel","volume":"54","author":"Chen","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.phymed.2026.158759_bib0026","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.phymed.2026.158759_bib0027","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2019.12.011","article-title":"Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity","volume":"318","author":"Cheng","year":"2020","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0028","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1083\/jcb.201904004","article-title":"Quantitative glycoproteomics reveals new classes of STT3A- and STT3B-dependent N-glycosylation sites","volume":"218","author":"Cherepanova","year":"2019","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158759_bib0029","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1124\/dmd.118.080663","article-title":"Beyond competitive inhibition: regulation of ABC transporters by kinases and protein-protein interactions as potential mechanisms of drug-drug interactions","volume":"46","author":"Crawford","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phymed.2026.158759_bib0030","article-title":"The role of long non-coding RNAs in developing paclitaxel-resistant triple negative breast cancer: a systematic review","volume":"43","author":"Dalil","year":"2025","journal-title":"Cancer Treat. Res. Commun."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010198","article-title":"Targeting aberrant RAS\/RAF\/MEK\/ERK signaling for cancer therapy","volume":"9","author":"Degirmenci","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phymed.2026.158759_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1547992","article-title":"Synergistic chemotherapy and immunomodulatory effects of Quercetin in cancer: a review","volume":"16","author":"Deng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2026.158759_bib0033","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.phymed.2026.158759_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/or.2022.10568","article-title":"NF-\u03baB signaling in tumor pathways focusing on breast and ovarian cancer","volume":"16","author":"Devanaboyina","year":"2022","journal-title":"Oncol. Rev."},{"issue":"18","key":"10.1016\/j.phymed.2026.158759_bib0035","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1080\/09205063.2025.2510441","article-title":"Nanostructured solid lipid for paclitaxel and kaempferol co-delivery as a novel synergistic approach for breast cancer","volume":"36","author":"Dewangan","year":"2025","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112559","article-title":"Epigenetic activation of BRCA1 by genistein in vivo and triple negative breast cancer cells linked to antagonism toward aryl hydrocarbon receptor","volume":"11","author":"Donovan","year":"2019","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.phymed.2026.158759_bib0037","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1039\/D5RE00261C","article-title":"Copper-based metal\u2013organic frameworks as highly efficient catalysts for the biomimetic catalytic synthesis of theaflavins","volume":"10","author":"Du","year":"2025","journal-title":"React. Chem. Eng."},{"issue":"7","key":"10.1016\/j.phymed.2026.158759_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202200435","article-title":"A review on dietary flavonoids as modulators of the tumor microenvironment","volume":"67","author":"Duan","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phymed.2026.158759_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1648395","article-title":"Exploring the pharmacokinetics, drug-likeness, and toxicological features of anticancer flavonoids: a Boulevard to explore their clinical translational potential","volume":"16","author":"Dubey","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0040","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1158\/1078-0432.CCR-17-1912","article-title":"Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann's refined classification","volume":"24","author":"Echavarria","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0041","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41416-024-02875-5","article-title":"The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy","volume":"131","author":"Egeland","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2026.158759_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.758733","article-title":"Role of flavonoids as epigenetic modulators in cancer prevention and therapy","volume":"12","author":"Fatima","year":"2021","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.phymed.2026.158759_bib0043","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.apsb.2019.07.007","article-title":"Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents","volume":"10","author":"Feng","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2026.158759_bib0044","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.biopha.2016.11.130","article-title":"Plant-derived flavone Apigenin: the small-molecule with promising activity against therapeutically resistant prostate cancer","volume":"85","author":"Ganai","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2026.158759_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116850","article-title":"Strategic advancements in targeting the PI3K\/AKT\/mTOR pathway for breast cancer therapy","volume":"236","author":"Garg","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158759_bib0046","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3390\/cancers2021288","article-title":"Interfering with ROS metabolism in cancer cells: the potential role of quercetin","volume":"2","author":"Gibellini","year":"2010","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0047","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1158\/1541-7786.MCR-19-0040","article-title":"The altered transcriptome and DNA methylation profiles of docetaxel resistance in breast cancer PDX models","volume":"17","author":"G\u00f3mez-Miragaya","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158759_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111959","article-title":"Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo","volume":"132","author":"Gong","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0049","article-title":"Targeting ferroptosis with flavonoids for cancer therapy: mechanisms and opportunities","volume":"1881","author":"Gong","year":"2026","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"issue":"6","key":"10.1016\/j.phymed.2026.158759_bib0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, Inflammation, and Cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0051","doi-asserted-by":"crossref","DOI":"10.1186\/s43141-020-00077-z","article-title":"Antioxidant or pro-oxidant and glutathione transferase P1-1 inhibiting activities for Tamarindus indica seeds and their cytotoxic effect on MCF-7 cancer cell line","volume":"18","author":"Guneidy","year":"2020","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0052","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14617","article-title":"Puerarin decreases the expression of FUS-dependent MAPK4 to inhibit the development of triple-negative breast cancer","volume":"104","author":"Guo","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0053","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0054","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12951-025-03252-x","article-title":"Metal\u2013organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances, challenges, and future perspectives","volume":"23","author":"Guo","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.phymed.2026.158759_bib0055","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0056","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.phymed.2026.158759_bib0057","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3390\/cancers17132232","article-title":"The PI3K\/Akt\/mTOR signaling pathway in triple-negative breast cancer: a resistance pathway and a prime target for targeted therapies","volume":"17","author":"Hassan","year":"2025","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.phymed.2026.158759_bib0058","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11122352","article-title":"Contribution of Non-coding RNAs to anticancer effects of dietary polyphenols: chlorogenic acid, curcumin, epigallocatechin-3-gallate, genistein, quercetin and resveratrol","volume":"11","author":"Hayakawa","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.phymed.2026.158759_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117347","article-title":"Flavonoids as modulators of miRNA expression in pancreatic cancer: pathways, mechanisms, and therapeutic potential","volume":"179","author":"Helen","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.phymed.2026.158759_bib0060","first-page":"3842","article-title":"Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase","volume":"17","author":"Huang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0061","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/abbs\/gmy117","article-title":"Bcl-3 promotes proliferation and chemosensitivity in BL1 subtype of TNBC cells","volume":"50","author":"Huo","year":"2018","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"35","key":"10.1016\/j.phymed.2026.158759_bib0062","doi-asserted-by":"crossref","first-page":"56767","DOI":"10.18632\/oncotarget.10790","article-title":"Delphinidin induces apoptosis via cleaved HDAC3-mediated p53 acetylation and oligomerization in prostate cancer cells","volume":"7","author":"Jeong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2026.158759_bib0063","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.talanta.2019.03.057","article-title":"Biocompatible Au@Ag nanorod@ZIF-8 core-shell nanoparticles for surface-enhanced Raman scattering imaging and drug delivery","volume":"200","author":"Jiang","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.phymed.2026.158759_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111489","article-title":"Flavonoids and their role in oxidative stress, inflammation, and human diseases","volume":"413","author":"Jomova","year":"2025","journal-title":"Chem.-Biol. Interact."},{"issue":"5","key":"10.1016\/j.phymed.2026.158759_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010960","article-title":"Paclitaxel, interferons and functional reprogramming of tumor-associated macrophages in optimized chemo-immunotherapy","volume":"13","author":"Kalinski","year":"2025","journal-title":"J. ImmunOther Cancer"},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0066","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.bbagen.2012.12.005","article-title":"The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells","volume":"1830","author":"Kang","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA) - Gen. Subj."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0067","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mc.21939","article-title":"Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1","volume":"53","author":"Kanwal","year":"2012","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.phymed.2026.158759_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1579135","article-title":"The implication of aberrant NRF2 activation in management of female cancers","volume":"15","author":"Kgatle","year":"2025","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.phymed.2026.158759_bib0069","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1007\/s00210-025-04078-y","article-title":"The effects of flavonoid baicalein on miRNA expressions in cancer: a systematic review","volume":"398","author":"Khandan","year":"2025","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0070","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/med.21933","article-title":"Ferroptosis-modulating small molecules for targeting drug-resistant cancer: challenges and opportunities in manipulating redox signaling","volume":"43","author":"Koeberle","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.phymed.2026.158759_bib0071","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25020252","article-title":"Inhibitory effect of hesperidin on the expression of programmed death ligand (PD-L1) in breast cancer","volume":"25","author":"Kongtawelert","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0072","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10555-023-10134-x","article-title":"Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling","volume":"43","author":"Kubatka","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.phymed.2026.158759_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117313","article-title":"DNA methylation as an oncogenic driver in breast cancer: therapeutic targeting via epigenetic reprogramming of DNA methyltransferases","volume":"242","author":"Kundu","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0074","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41401-024-01258-z","article-title":"Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2\/STAT3\/GPX4 axis","volume":"45","author":"Lai","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"19","key":"10.1016\/j.phymed.2026.158759_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194719","article-title":"Latest advances in targeting the tumor microenvironment for tumor suppression","volume":"20","author":"Laplagne","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27010450","article-title":"Overcoming therapeutic resistance in triple-negative breast cancer: targeting the Undrugged Kinome","volume":"27","author":"Lee","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0077","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1038\/s41467-021-26502-6","article-title":"Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes","volume":"12","author":"Lehmann","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0078","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49136-8","article-title":"Gankyrin inhibits ferroptosis through the p53\/SLC7A11\/GPX4 axis in triple-negative breast cancer cells","volume":"13","author":"Lei","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.phymed.2026.158759_bib0079","doi-asserted-by":"crossref","DOI":"10.3390\/biology14050545","article-title":"Ferroptosis: therapeutic potential and strategies in non-small cell lung cancer","volume":"14","author":"Lei","year":"2025","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0080","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1186\/s12885-023-11724-2","article-title":"CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK\/ERK signaling pathway","volume":"23","author":"Li","year":"2023","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.phymed.2026.158759_bib0081","article-title":"Erastin triggers autophagic death of breast cancer cells by increasing intracellular iron levels","author":"Li","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phymed.2026.158759_bib0082","article-title":"Natural flavonoids from herbs and nutraceuticals as ferroptosis inhibitors in central nervous system diseases: current preclinical evidence and future perspectives","volume":"16","author":"Li","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0083","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/ptr.6081","article-title":"Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation","volume":"32","author":"Li","year":"2018","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2026.158759_bib0084","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.2147\/IJN.S509877","article-title":"Quercetin and nano-derivatives: potential and challenges in cancer therapy","volume":"20","author":"Li","year":"2025","journal-title":"Int J Nanomed."},{"key":"10.1016\/j.phymed.2026.158759_bib0085","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.2147\/IJN.S497510","article-title":"Overcoming biological barriers in cancer therapy: cell membrane-based nanocarrier strategies for precision delivery","volume":"20","author":"Li","year":"2025","journal-title":"Int J Nanomed."},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0086","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158759_bib0087","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3892\/or.2016.5311","article-title":"Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of beta-catenin expression","volume":"37","author":"Lin","year":"2017","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0088","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1111\/cas.15916","article-title":"Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes","volume":"114","author":"Liu","year":"2023","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.phymed.2026.158759_bib0089","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7150\/ijms.24981","article-title":"The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer","volume":"15","author":"Liu","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.phymed.2026.158759_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101349","article-title":"AMPKalpha2 attenuates doxorubicin induced ferroptosis by promoting NCOA4 degradation in triple negative breast cancer","volume":"85","author":"Liu","year":"2026","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.phymed.2026.158759_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107570","article-title":"Wogonin effects on the efflux transporters BCRP and MRP2, explain its effectiveness in ulcerative colitis: implications for metabolic and transport interactions","volume":"212","author":"Liu","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"38","key":"10.1016\/j.phymed.2026.158759_bib0092","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1073\/pnas.1806034115","article-title":"Mammalian STT3A\/B oligosaccharyltransferases segregate N-glycosylation at the translocon from lipid-linked oligosaccharide hydrolysis","volume":"115","author":"Lu","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0093","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03539-z","article-title":"Carrier-free nano-integrated strategy of phototherapy and chemotherapy for synergetic AKT targeted therapy to inhibit cancer metastasis and recurrence","volume":"23","author":"Lu","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0094","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s44320-024-00047-4","article-title":"Dynamical and combinatorial coding by MAPK p38 and NF\u03baB in the inflammatory response of macrophages","volume":"20","author":"Luecke","year":"2024","journal-title":"Mol. Syst. Biol."},{"issue":"40","key":"10.1016\/j.phymed.2026.158759_bib0095","article-title":"A dual-targeting liposome enhances triple-negative breast cancer chemoimmunotherapy through inducing immunogenic cell death and inhibiting STAT3 activation","volume":"19","author":"Luo","year":"2023","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0096","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41420-024-02195-w","article-title":"Mechanisms of ferroptosis and targeted therapeutic approaches in urological malignancies","volume":"10","author":"Ma","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.phymed.2026.158759_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111760","article-title":"Apatinib combined with paclitaxel suppresses synergistically TNBC progression through enhancing ferroptosis susceptibility regulated SLC7A11\/GPX4\/ACSL4 axis","volume":"131","author":"Ma","year":"2025","journal-title":"Cell Signal."},{"key":"10.1016\/j.phymed.2026.158759_bib0098","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1499950","article-title":"Unlocking the epigenetic code: new insights into triple-negative breast cancer","volume":"14","author":"Mahendran","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0099","doi-asserted-by":"crossref","first-page":"230S","DOI":"10.1093\/ajcn\/81.1.230S","article-title":"Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies2","volume":"81","author":"Manach","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.phymed.2026.158759_bib0101","doi-asserted-by":"crossref","DOI":"10.3390\/biom13040688","article-title":"The multifaceted role of glutathione S-transferases in health and disease","volume":"13","author":"Mazari","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.phymed.2026.158759_bib0102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1366197","article-title":"Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model","volume":"15","author":"Mediratta","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.phymed.2026.158759_bib0103","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends. Biochem. Sci."},{"issue":"1-2","key":"10.1016\/j.phymed.2026.158759_bib0104","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijpharm.2016.09.001","article-title":"Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition","volume":"513","author":"Meng","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03542-2","article-title":"Improving the drug delivery performance of ZIF-8 with amine functionalization as a 5-fluorouracil nanocarrier","volume":"15","author":"Mirzanejad","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158759_bib0106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.colsurfb.2018.10.072","article-title":"Reversing multi-drug tumor resistance to paclitaxel by well-defined pH-sensitive amphiphilic polypeptide block copolymers via induction of lysosomal membrane permeabilization","volume":"174","author":"Mostoufi","year":"2019","journal-title":"Colloids. Surf. B Biointerfaces."},{"issue":"5","key":"10.1016\/j.phymed.2026.158759_bib0107","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.actbio.2013.12.041","article-title":"Sequentially releasing dual-drug-loaded PLGA-casein core\/shell nanomedicine: design, synthesis, biocompatibility and pharmacokinetics","volume":"10","author":"Narayanan","year":"2014","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0108","doi-asserted-by":"crossref","DOI":"10.1155\/bmri\/5824748","article-title":"Restoring tamoxifen sensitivity in breast cancer: the role of lncRNA MALAT1 and NanoCurcumin as modulators of drug resistance","volume":"2025","author":"Nasiri Kenari","year":"2025","journal-title":"BioMed Res. Int."},{"issue":"9","key":"10.1016\/j.phymed.2026.158759_bib0109","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge","volume":"8","author":"Nedeljkovi\u0107","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0110","doi-asserted-by":"crossref","DOI":"10.1007\/s10616-026-00892-1","article-title":"Isolating cancer stem cells in breast cancer models: a study of CD marker expression and Rhodamine 123 as predictors of chemoresistance","volume":"78","author":"Ok\u015fak","year":"2026","journal-title":"Cytotechnology"},{"key":"10.1016\/j.phymed.2026.158759_bib0111","series-title":"The Global Breast Cancer Initiative","author":"Organization","year":"2014"},{"issue":"5","key":"10.1016\/j.phymed.2026.158759_bib0112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096228","article-title":"MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer","volume":"9","author":"Ouyang","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.phymed.2026.158759_bib0113","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/mc.20866","article-title":"Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study","volume":"51","author":"Pandey","year":"2011","journal-title":"Mol. Carcinog."},{"issue":"7","key":"10.1016\/j.phymed.2026.158759_bib0114","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/cancers11070965","article-title":"Targeting cancer stem cells in triple-negative breast cancer","volume":"11","author":"Park","year":"2019","journal-title":"Cancers"},{"issue":"35","key":"10.1016\/j.phymed.2026.158759_bib0115","doi-asserted-by":"crossref","first-page":"37526","DOI":"10.18632\/oncotarget.6063","article-title":"Combinatorial TGF-\u03b2 attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells","volume":"6","author":"Park","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.phymed.2026.158759_bib0116","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamcr.2010.12.012","article-title":"The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation","volume":"1813","author":"Plotnikov","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0117","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1002\/ptr.7267","article-title":"Luteolin combined with low-dose paclitaxel synergistically inhibits epithelial-mesenchymal transition and induces cell apoptosis on esophageal carcinoma in vitro and in vivo","volume":"35","author":"Qin","year":"2021","journal-title":"PhytOther Res."},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0118","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1002\/ptr.7267","article-title":"Luteolin combined with low-dose paclitaxel synergistically inhibits epithelial\u2013mesenchymal transition and induces cell apoptosis on esophageal carcinoma in vitro and in vivo","volume":"35","author":"Qin","year":"2021","journal-title":"Phytother. Res."},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0119","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.phymed.2026.158759_bib0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jclinpath-2021-207487","article-title":"Specific cell differentiation in breast cancer: a basis for histological classification","volume":"75","author":"Rakha","year":"2022","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.phymed.2026.158759_bib0121","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.colsurfb.2014.11.005","article-title":"Paclitaxel\/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells","volume":"125","author":"Ramadass","year":"2015","journal-title":"Colloids. Surf. B Biointerfaces."},{"issue":"9","key":"10.1016\/j.phymed.2026.158759_bib0122","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70803","article-title":"Targeting triple-negative breast cancer: resistance mechanisms and therapeutic advancements","volume":"14","author":"Raman","year":"2025","journal-title":"Cancer Med."},{"issue":"13","key":"10.1016\/j.phymed.2026.158759_bib0123","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137280","article-title":"Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease","volume":"23","author":"Ramanathan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0124","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-025-04308-5","article-title":"Advances in nanoparticle-based doxorubicin delivery: precision strategies for targeted treatment of triple-negative breast cancer","volume":"20","author":"Ramayanam","year":"2025","journal-title":"Discov. Nano"},{"issue":"6","key":"10.1016\/j.phymed.2026.158759_bib0125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41419-024-06831-2","article-title":"ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability","volume":"15","author":"Reddi","year":"2024","journal-title":"Cell Death. Dis."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0126","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2016.03.040","article-title":"The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters","volume":"376","author":"Rigalli","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2026.158759_bib0127","article-title":"Advancement in triple-negative breast cancer therapeutics: a comprehensive review on the potential of cell membrane-coated nanoparticles","volume":"98","author":"Rout","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0128","doi-asserted-by":"crossref","DOI":"10.3390\/ceramics8030113","article-title":"ZIF-8 as a drug delivery system (DDS) for hesperidin: synthesis, characterization, and in vitro release profile","volume":"8","author":"S\u00e1","year":"2025","journal-title":"Ceramics"},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0129","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400153","article-title":"Preclinical development of a genetically engineered albumin-binding nanoparticle of paclitaxel","volume":"4","author":"Saha","year":"2024","journal-title":"Small. Sci."},{"issue":"6","key":"10.1016\/j.phymed.2026.158759_bib0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061305","article-title":"The therapeutic potential of apigenin","volume":"20","author":"Salehi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phymed.2026.158759_bib0131","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.19.00368","article-title":"Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: the PAKT trial","volume":"38","author":"Schmid","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0132","article-title":"Tumour Microenvironment stress promotes the development of drug resistance","volume":"10","author":"Seebacher","year":"2021","journal-title":"Antioxid. (Basel)"},{"issue":"22","key":"10.1016\/j.phymed.2026.158759_bib223","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178617","article-title":"Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells","volume":"134","author":"Shen","year":"2024","journal-title":"J. Clin. Invest"},{"issue":"16","key":"10.1016\/j.phymed.2026.158759_bib0133","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24162899","article-title":"The inhibitory effect of (\u2212)-epigallocatechin-3-gallate on breast cancer progression via reducing SCUBE2 methylation and DNMT activity","volume":"24","author":"Sheng","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0134","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15080","article-title":"Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth","volume":"8","author":"Shi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2026.158759_bib0135","article-title":"Flavonoid-mediated modulation of ferroptosis: therapeutic potential in gastrointestinal cancers","author":"Shoheeduzzaman","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.phymed.2026.158759_bib0136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117424","article-title":"Multifunctional metal-organic frameworks in breast cancer therapy: advanced nanovehicles for effective treatment","volume":"289","author":"Shukla","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2026.158759_bib0137","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1455211","article-title":"Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer","volume":"15","author":"Singh","year":"2024","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.phymed.2026.158759_bib0138","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215373","article-title":"Luteolin, a potent anticancer compound: from chemistry to cellular interactions and synergetic perspectives","volume":"14","author":"Singh Tuli","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0139","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43046-024-00246-y","article-title":"Galangin promotes apoptosis by upregulating the pro-apoptotic gene BAX in triple-negative breast cancer","volume":"36","author":"Sinnarkar","year":"2024","journal-title":"J. Egypt. Natl. Canc. Inst."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct. Target. Ther"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0141","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11010133","article-title":"Revisiting the oxidation of flavonoids: loss, conservation or enhancement of their antioxidant properties","volume":"11","author":"Speisky","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0142","doi-asserted-by":"crossref","DOI":"10.1038\/srep24049","article-title":"Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis","volume":"6","author":"Srivastava","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158759_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113121","article-title":"Pathogenesis of paclitaxel-induced peripheral neuropathy: a current review of in vitro and in vivo findings using rodent and human model systems","volume":"324","author":"Staff","year":"2020","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0144","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/2211738508666200421113215","article-title":"Metal-organic nanopharmaceuticals","volume":"8","author":"Steinborn","year":"2020","journal-title":"Pharm. Nanotechnol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158759_bib0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0146","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1038\/s41598-020-66419-6","article-title":"Hesperidin loaded on gold nanoparticles as a drug delivery system for a successful biocompatible, anti-cancer, anti-inflammatory and phagocytosis inducer model","volume":"10","author":"Sulaiman","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0147","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1038\/s41598-020-66419-6","article-title":"Hesperidin loaded on gold nanoparticles as a drug delivery system for a successful biocompatible, anti-cancer, anti-inflammatory and phagocytosis inducer model","volume":"10","author":"Sulaiman","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.phymed.2026.158759_bib0148","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.phymed.2026.158759_bib0149","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106419","article-title":"Flavonoids regulate tumor-associated macrophages \u2013 From structure-activity relationship to clinical potential (Review)","volume":"184","author":"Sun","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2026.158759_bib0150","article-title":"Synergistic ROS\/enzyme dual-responsive oral drug delivery system: a novel multi-mechanistic platform for spatiotemporal control and overcoming drug resistance in colorectal cancer therapy","volume":"33","author":"Sun","year":"2025","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.phymed.2026.158759_bib0151","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1478-811X-11-69","article-title":"B-cell translocation gene 2 mediates crosstalk between PI3K\/Akt1 and NF\u03baB pathways which enhances transcription of MnSOD by accelerating I\u03baB\u03b1 degradation in normal and cancer cells","volume":"11","author":"Sundaramoorthy","year":"2013","journal-title":"Cell Commun. Signal."},{"issue":"7","key":"10.1016\/j.phymed.2026.158759_bib0152","article-title":"Enhanced apoptotic effects in MDA-MB-231 triple-negative breast cancer cells through a synergistic action of luteolin and paclitaxel","volume":"16","author":"Tamanna","year":"2024","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0153","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.271","article-title":"Autophagy-induced RelB\/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin","volume":"6","author":"Tan","year":"2015","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0154","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3945\/jn.110.121905","article-title":"Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells","volume":"140","author":"Tan","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.phymed.2026.158759_bib0155","doi-asserted-by":"crossref","first-page":"15185","DOI":"10.2147\/IJN.S568952","article-title":"Self-assembled nanoparticles: overcoming limitations of conventional nanomedicines for enhanced tumor therapy","volume":"20","author":"Tang","year":"2025","journal-title":"Int J Nanomed."},{"issue":"2","key":"10.1016\/j.phymed.2026.158759_bib0156","doi-asserted-by":"crossref","first-page":"357","DOI":"10.32604\/biocell.2022.015958","article-title":"The potential toxic side effects of flavonoids","volume":"46","author":"Tang","year":"2022","journal-title":"Biocell"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0157","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11010-014-2317-7","article-title":"Quercetin inhibits proliferation and invasion acts by up-regulating miR-146a in human breast cancer cells","volume":"402","author":"Tao","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phymed.2026.158759_bib0158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","article-title":"Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy","volume":"80","author":"Tewari","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0159","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","article-title":"Molecular classification of breast cancer","volume":"27","author":"Tsang","year":"2020","journal-title":"Adv. Anat. Pathol."},{"issue":"22","key":"10.1016\/j.phymed.2026.158759_bib0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225243","article-title":"Important flavonoids and their role as a therapeutic agent","volume":"25","author":"Ullah","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0161","doi-asserted-by":"crossref","DOI":"10.3390\/ph18101486","article-title":"Flavonoid-based combination therapies and nano-formulations: an emerging frontier in breast cancer treatment","volume":"18","author":"Uniyal","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.phymed.2026.158759_bib0162","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0009-2797(02)00250-8","article-title":"Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin","volume":"145","author":"van Zanden","year":"2003","journal-title":"Chem.-Biol. Interact."},{"issue":"8","key":"10.1016\/j.phymed.2026.158759_bib0163","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.bcp.2003.12.032","article-title":"Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells","volume":"67","author":"van Zanden","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158759_bib0164","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108623","article-title":"Current methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatment","volume":"94","author":"Vazhappilly","year":"2021","journal-title":"J. Nutr. Biochem."},{"issue":"9","key":"10.1016\/j.phymed.2026.158759_bib0165","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10147-023-02378-y","article-title":"Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer","volume":"28","author":"Wang","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0166","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s13258-025-01669-0","article-title":"Targeting the miR-325-3p\/GSTP1 axis overcomes paclitaxel resistance in triple-negative breast cancer by inducing ferroptosis","volume":"47","author":"Wang","year":"2025","journal-title":"Genes Genom."},{"issue":"4","key":"10.1016\/j.phymed.2026.158759_bib0167","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41401-024-01419-0","article-title":"STT3-mediated aberrant N-glycosylation of CD24 inhibits paclitaxel sensitivity in triple-negative breast cancer","volume":"46","author":"Wang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.phymed.2026.158759_bib0168","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.343","article-title":"Hot and cold tumors: immunological features and the therapeutic strategies","volume":"4","author":"Wang","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0169","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-021-01332-8","article-title":"CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K\/AKT pathway","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2026.158759_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156701","article-title":"Kaempferol targets Src to exert its chemopreventive effects on mammary tumorigenesis via regulation of the PI3K\/AKT pathway","volume":"141","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158759_bib0171","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156701","article-title":"Kaempferol targets Src to exert its chemopreventive effects on mammary tumorigenesis via regulation of the PI3K\/AKT pathway","volume":"141","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.phymed.2026.158759_bib0172","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.7150\/thno.30716","article-title":"Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.phymed.2026.158759_bib0173","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.actbio.2020.05.026","article-title":"Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery","volume":"111","author":"Wang","year":"2020","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0174","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s43018-025-01029-7","article-title":"A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer","volume":"6","author":"Wang","year":"2025","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031464","article-title":"MAPK\/ERK pathway as a central regulator in vertebrate organ regeneration","volume":"23","author":"Wen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0176","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41420-025-02743-y","article-title":"Targeting the redox-programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance","volume":"11","author":"Wen","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0177","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther"},{"key":"10.1016\/j.phymed.2026.158759_bib0178","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101288","article-title":"Drug resistance in breast cancer: mechanisms and strategies for management","volume":"83","author":"Wu","year":"2025","journal-title":"Drug Resist. Updat."},{"issue":"19","key":"10.1016\/j.phymed.2026.158759_bib0179","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1097\/CM9.0000000000003758","article-title":"GSTP1-mediated inhibition of ACSL4-dependent ferroptosis via JNK pathway in DOX-induced cardiomyopathy","volume":"138","author":"Wu","year":"2025","journal-title":"Chin. Med. J."},{"issue":"6","key":"10.1016\/j.phymed.2026.158759_bib0180","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1016\/j.apsb.2025.04.006","article-title":"Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery","volume":"15","author":"Wu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2026.158759_bib0181","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157074","article-title":"Nobiletin promotes ferroptosis in breast cancer through targeting AKR1C1-mediated ubiquitination and degradation of GPX4","volume":"146","author":"Wu","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0182","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"12","key":"10.1016\/j.phymed.2026.158759_bib0183","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122770","article-title":"Cell membrane biomimetic nano-delivery systems for cancer therapy","volume":"15","author":"Xia","year":"2023","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0184","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/ijc.24249","article-title":"Induction of myeloid-derived suppressor cells by tumor exosomes","volume":"124","author":"Xiang","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.phymed.2026.158759_bib0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","article-title":"Comprehensive metabolomics expands precision medicine for triple-negative breast cancer","volume":"32","author":"Xiao","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.phymed.2026.158759_bib0186","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1441105","article-title":"Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1\/SREBP1\/SCD1 pathway","volume":"15","author":"Xie","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158759_bib0187","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119769","article-title":"Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model","volume":"235","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"issue":"39","key":"10.1016\/j.phymed.2026.158759_bib0188","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039845","article-title":"Triple-negative breast cancer treatment with core-shell Magnetic@Platinium-Metal organic framework\/epirubicin nano-platforms for chemo-photodynamic based combinational therapy: a review","volume":"103","author":"Xu","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.phymed.2026.158759_bib0189","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.2147\/IJN.S182621","article-title":"Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells","volume":"13","author":"Xu","year":"2018","journal-title":"Int J Nanomed."},{"key":"10.1016\/j.phymed.2026.158759_bib0190","article-title":"Biomimetic tumor cell membrane-camouflaged nanomicelles for synergistic chemo-immunotherapy of Triple-negative breast cancer","volume":"33","author":"Xu","year":"2025","journal-title":"Mater. Today Bio."},{"issue":"2","key":"10.1016\/j.phymed.2026.158759_bib0191","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bcp.2014.09.008","article-title":"Wogonin reverses multi-drug resistance of human myelogenous leukemia K562\/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2\/ARE signaling pathway","volume":"92","author":"Xu","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158759_bib0192","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123209","article-title":"Ratiometric codelivery of Paclitaxel and Baicalein loaded nanoemulsion for enhancement of breast cancer treatment","volume":"643","author":"Yadav","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.phymed.2026.158759_bib0193","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3892\/mmr.2025.13515","article-title":"Advances in research on flavonoids in tumor immunotherapy (Review)","volume":"31","author":"Yan","year":"2025","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0194","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1007\/s12672-025-03745-z","article-title":"From cold to hot tumors: feasibility of applying therapeutic insights to TNBC","volume":"16","author":"Yan","year":"2025","journal-title":"Discov. Oncol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158759_bib0195","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1007\/s00204-020-02842-y","article-title":"Wogonin induces cellular senescence in breast cancer via suppressing TXNRD2 expression","volume":"94","author":"Yang","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0196","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2026.158759_bib0197","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2021.04.013","article-title":"Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy","volume":"334","author":"Yang","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0198","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"0","key":"10.1016\/j.phymed.2026.158759_bib0199","first-page":"1","article-title":"Ferroptosis-related signaling pathways in cancer drug resistance","volume":"8","author":"Yang","year":"2025","journal-title":"Cancer Drug Resist."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0200","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1186\/s12967-025-07370-w","article-title":"Recent progress in immune evasion mechanisms of triple-negative breast cancer","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0201","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00210-023-02510-9","article-title":"Exploring the mechanism by which quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology, molecular docking, and experimental verification","volume":"396","author":"Yang","year":"2023","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0202","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00210-023-02510-9","article-title":"Exploring the mechanism by which quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology, molecular docking, and experimental verification","volume":"396","author":"Yang","year":"2023","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158759_bib0203","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113474","article-title":"CCL2 overexpression is associated with paclitaxel resistance in ovarian cancer cells via autocrine signaling and macrophage recruitment","volume":"153","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0204","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccell.2024.11.008","article-title":"Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.phymed.2026.158759_bib0205","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.7150\/thno.21516","article-title":"pH-sensitive nano-complexes overcome drug resistance and inhibit metastasis of breast cancer by silencing Akt expression","volume":"7","author":"Yin","year":"2017","journal-title":"Theranostics"},{"issue":"25","key":"10.1016\/j.phymed.2026.158759_bib0206","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1016\/j.cell.2024.09.024","article-title":"Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer","volume":"187","author":"You","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2026.158759_bib0207","article-title":"Flavonoids: a natural remedy in the prevention and management of diverse diseases","volume":"12","author":"Yu","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.phymed.2026.158759_bib0208","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1713869","article-title":"Flavonoids: a natural remedy in the prevention and management of diverse diseases","volume":"12","author":"Yu","year":"2025","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.phymed.2026.158759_bib0209","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12282-024-01567-5","article-title":"PI3K\/AKT\/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer","volume":"31","author":"Zhang","year":"2024","journal-title":"Breast. Cancer"},{"key":"10.1016\/j.phymed.2026.158759_bib0210","doi-asserted-by":"crossref","DOI":"10.1177\/15347354231210867","article-title":"Licochalcone A induces ferroptosis in hepatocellular carcinoma via reactive oxygen species activated by the SLC7A11\/GPX4 pathway","volume":"22","author":"Zhang","year":"2023","journal-title":"Integr. Cancer Ther."},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0211","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/acsami.1c20031","article-title":"Self-delivery janus-prodrug for precise immuno-chemotherapy of colitis-associated colorectal cancer","volume":"14","author":"Zhang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"14","key":"10.1016\/j.phymed.2026.158759_bib0212","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141820","article-title":"Ferroptosis in cancer progression","volume":"12","author":"Zhang","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phymed.2026.158759_bib0213","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12935-020-01260-5","article-title":"EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress","volume":"20","author":"Zhang","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"23","key":"10.1016\/j.phymed.2026.158759_bib0214","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","article-title":"SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation","volume":"83","author":"Zhang","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2026.158759_bib0215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2147\/OTT.S228453","article-title":"Quercetin enhanced paclitaxel therapeutic effects towards PC-3 prostate cancer through ER stress induction and ROS production","volume":"13","author":"Zhang","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.phymed.2026.158759_bib0216","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.2147\/CMAR.S551549","article-title":"The role of SLC7A11 in tumor progression and the regulation mechanisms involved in ferroptosis","volume":"17","author":"Zhang","year":"2025","journal-title":"Cancer Manage. Res."},{"issue":"3","key":"10.1016\/j.phymed.2026.158759_bib0217","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","article-title":"Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.phymed.2026.158759_bib0218","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.7150\/thno.52028","article-title":"Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"31","key":"10.1016\/j.phymed.2026.158759_bib0219","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.2174\/0929867327666201111143725","article-title":"Recent advances in paclitaxel-based self-delivery nanomedicine for cancer therapy","volume":"28","author":"Zhou","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"11","key":"10.1016\/j.phymed.2026.158759_bib0220","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1055\/s-0034-1376977","article-title":"Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K\/AKT signaling pathways","volume":"46","author":"Zhou","year":"2014","journal-title":"Horm. Metab. Res."},{"issue":"38","key":"10.1016\/j.phymed.2026.158759_bib0221","doi-asserted-by":"crossref","first-page":"21033","DOI":"10.1002\/anie.202108658","article-title":"Exquisite vesicular nanomedicine by paclitaxel mediated Co-assembly with camptothecin prodrug","volume":"60","author":"Zhou","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"22","key":"10.1016\/j.phymed.2026.158759_bib0222","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212455","article-title":"Targeting PI3K\/Akt\/mTOR pathway by different flavonoids: a cancer chemopreventive approach","volume":"22","author":"Zughaibi","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326009906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326009906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:08:40Z","timestamp":1793192920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326009906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":222,"alternative-id":["S0944711326009906"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158759","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From molecular to microenvironmental reprogramming: Multi-target strategies of flavonoids to overcome paclitaxel resistance in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158759"}}